gamma-aminobutyric acid has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 4 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gamma-aminobutyric acid is a major inhibitory neurotransmitter in the central nervous system." | 2.44 | [Gamma-aminobutyric acid--metabolism and its disorders]. ( Kowalski, A; Rebas, E; Zylińska, L, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalski, A | 1 |
| Rebas, E | 1 |
| Zylińska, L | 1 |
| Moore, AR | 1 |
| Straube, S | 1 |
| Paine, J | 1 |
| Phillips, CJ | 1 |
| Derry, S | 1 |
| McQuay, HJ | 1 |
| Murrough, JW | 1 |
| Mao, X | 1 |
| Collins, KA | 1 |
| Kelly, C | 1 |
| Andrade, G | 1 |
| Nestadt, P | 1 |
| Levine, SM | 1 |
| Mathew, SJ | 1 |
| Shungu, DC | 1 |
| Hannestad, U | 1 |
| Theodorsson, E | 1 |
| Evengård, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cannabidiol for Fibromyalgia -The CANNFIB Trial Protocol for a Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial[NCT04729179] | Phase 3 | 200 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gamma-aminobutyric acid and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
[Gamma-aminobutyric acid--metabolism and its disorders].
Topics: Anxiety Disorders; Central Nervous System Diseases; Fatigue Syndrome, Chronic; gamma-Aminobutyric Ac | 2007 |
1 trial available for gamma-aminobutyric acid and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain.
Topics: Activities of Daily Living; Adult; Analgesics; Fatigue Syndrome, Chronic; Female; Fibromyalgia; gamm | 2010 |
2 other studies available for gamma-aminobutyric acid and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.
Topics: Adult; Cerebral Ventricles; Depressive Disorder, Major; Fatigue Syndrome, Chronic; Female; gamma-Ami | 2010 |
beta-Alanine and gamma-aminobutyric acid in chronic fatigue syndrome.
Topics: Adult; beta-Alanine; Fatigue Syndrome, Chronic; Female; gamma-Aminobutyric Acid; Humans; Male; Middl | 2007 |